Toward aggregation-resistant antibodies by design

Christine C. Lee, Joseph M. Perchiacca, Peter M. Tessier.
• Therapeutic antibodies possess highly variable propensities to aggregate.
• Antibody CDRs, frameworks, and domain interfaces strongly influence solubility.
• Co....
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *



You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>